Stock
Reported value
—
Holders
—
Holders’ est. mark
—
Need a prior quarter
Largest holder
—
Holder count by quarter
Who holds it
Notable only| Investor | Shares | Value | Est. mark | Change |
|---|
Who left
- Atlas Venture Life Science Advisors, LLC$4.7M
- SymBiosis Capital Partners, LLC$3.78M
- Opaleye Management Inc.$1.76M
- Renaissance Technologies$1.63M
- Siren, L.L.C.$1.14M
- UBS Group AG$935.6K
- MORGAN STANLEY$916.6K
- MARSHALL WACE, LLP$796.9K
- Yiheng Capital Management, L.P.$599.4K
- Rangeley Capital, LLC$558.2K
- GOLDMAN SACHS GROUP INC$519.9K
- MILLENNIUM MANAGEMENT LLC$503K
- BANK OF AMERICA CORP /DE/$481.9K
- BlackRock, Inc.$341.2K
- GEODE CAPITAL MANAGEMENT, LLC$294.3K
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.